Robert Azelby
Equibles does not estimate personal net worth.
About Robert Azelby
Earlier roles on record: Board Member and CEO at Climb Bio, Inc. (CLYM) until February 13, 2023. Climb Bio, Inc. reported in an 8-K filed February 14, 2023 that Robert Azelby resigned as President, Chief Executive Officer and Director, effective February 13, 2023. The proxy statement of Climb Bio, Inc. reports total compensation of $5,161,000 for Robert Azelby in fiscal 2022, including a base salary of $675,000. Disclosed compensation is on record for 3 fiscal years.
“The Company and Mr. Azelby mutually agreed that Mr. Azelby will resign as President, Chief Executive Officer and as a member of the Board. Mr. Azelby's resignation from the foregoing offices and as a member of the Board is effective on February 13, 2023 (the "Azelby Separation Date").”
Affiliation history
-
Start not stated–2023-02-13
-
Start not stated–2023-02-13
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Climb Bio, Inc. (CLYM) | — | $675,000 | $5,161,000 |
| 2021 | Climb Bio, Inc. (CLYM) | — | $600,000 | $7,154,787 |
| 2020 | Climb Bio, Inc. (CLYM) | — | $150,000 | $228,000 |